Kunshan Kersen Science & Technology Co.,Ltd.
SSE:603626.SS
7.95 (CNY) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,382.263 | 2,596.57 | 3,423.661 | 4,147.039 | 3,467.021 | 2,127.272 | 2,408.32 | 2,164.958 | 1,302.779 | 1,090.313 | 404.73 | 262.351 | 136.927 | 72.824 |
| Cost of Revenue
| 3,201.707 | 2,372.148 | 2,924.511 | 3,388.596 | 2,902.063 | 1,740.33 | 1,828.561 | 1,529.979 | 884.987 | 670.279 | 263.111 | 153.125 | 89.077 | 52.973 |
| Gross Profit
| 180.556 | 224.423 | 499.151 | 758.443 | 564.959 | 386.942 | 579.76 | 634.979 | 417.793 | 420.034 | 141.62 | 109.226 | 47.851 | 19.851 |
| Gross Profit Ratio
| 0.053 | 0.086 | 0.146 | 0.183 | 0.163 | 0.182 | 0.241 | 0.293 | 0.321 | 0.385 | 0.35 | 0.416 | 0.349 | 0.273 |
| Reseach & Development Expenses
| 236.819 | 183.496 | 201.613 | 234.642 | 203.36 | 181.025 | 149.46 | 113.793 | 63.448 | 53.669 | 24.676 | 13.689 | 6.223 | 0 |
| General & Administrative Expenses
| 79.94 | 95.388 | 69.593 | 100.223 | 97.184 | 64.101 | 47.184 | 31.433 | 25.677 | 18.823 | 9.46 | 6.417 | 18.421 | 8.969 |
| Selling & Marketing Expenses
| 14.2 | 11.525 | 42.709 | 46.647 | 46.489 | 65.608 | 66.873 | 48.262 | 31.744 | 21.846 | 12.858 | 9.908 | 4.233 | 3.34 |
| SG&A
| 94.14 | 226.143 | 112.302 | 146.87 | 143.673 | 129.71 | 114.057 | 79.695 | 57.421 | 40.669 | 22.319 | 16.325 | 22.655 | 12.309 |
| Other Expenses
| 285.077 | 86.642 | 154.399 | 137.807 | 160.156 | 180.901 | 10.963 | 10.328 | 5.237 | 8.292 | 1.248 | 8.942 | 0.386 | 0.107 |
| Operating Expenses
| 616.036 | 588.239 | 468.313 | 519.319 | 507.19 | 491.636 | 424.197 | 316.737 | 195.946 | 156.014 | 73.777 | 49.652 | 23.002 | 12.416 |
| Operating Income
| -435.48 | -227.193 | 166.734 | 352.302 | 33.075 | -83.328 | 126.515 | 247.473 | 213.899 | 226.706 | 52.938 | 45.757 | 13.443 | 4.032 |
| Operating Income Ratio
| -0.129 | -0.087 | 0.049 | 0.085 | 0.01 | -0.039 | 0.053 | 0.114 | 0.164 | 0.208 | 0.131 | 0.174 | 0.098 | 0.055 |
| Total Other Income Expenses Net
| -84.739 | -57.336 | -11.643 | 1.116 | -97.062 | -119.896 | 10.963 | -21.135 | 5.226 | 8.243 | 0.993 | 4.836 | 0.386 | 0 |
| Income Before Tax
| -520.219 | -284.529 | 107.484 | 353.417 | -63.986 | -203.225 | 137.478 | 257.801 | 219.126 | 234.948 | 53.932 | 50.592 | 13.829 | 4.032 |
| Income Before Tax Ratio
| -0.154 | -0.11 | 0.031 | 0.085 | -0.018 | -0.096 | 0.057 | 0.119 | 0.168 | 0.215 | 0.133 | 0.193 | 0.101 | 0.055 |
| Income Tax Expense
| -43.389 | -3.116 | 20.706 | -16.139 | -9.459 | -12.692 | 13.018 | 35.398 | 30.23 | 36.711 | 8.955 | 7.957 | 2.945 | 0.807 |
| Net Income
| -476.83 | -281.413 | 86.779 | 369.027 | -54.527 | -190.533 | 124.683 | 222.404 | 188.896 | 198.237 | 44.976 | 42.635 | 10.884 | 3.224 |
| Net Income Ratio
| -0.141 | -0.108 | 0.025 | 0.089 | -0.016 | -0.09 | 0.052 | 0.103 | 0.145 | 0.182 | 0.111 | 0.163 | 0.079 | 0.044 |
| EPS
| -0.86 | -0.51 | 0.16 | 0.71 | -0.12 | -0.45 | 0.3 | 0.78 | 0.61 | 0.64 | 0.15 | 0.17 | 0.035 | 0.01 |
| EPS Diluted
| -0.86 | -0.51 | 0.16 | 0.71 | -0.12 | -0.45 | 0.3 | 0.78 | 0.61 | 0.64 | 0.15 | 0.17 | 0.035 | 0.01 |
| EBITDA
| -103.426 | 170.218 | 540.326 | 769.485 | 270.021 | 122.954 | 366.929 | 373.225 | 290.212 | 286.018 | 77.699 | 70.403 | 30.446 | 11.777 |
| EBITDA Ratio
| -0.031 | 0.066 | 0.158 | 0.186 | 0.078 | 0.058 | 0.152 | 0.172 | 0.223 | 0.262 | 0.192 | 0.268 | 0.222 | 0.162 |